enya
qing
tom
gallagh
atyp
pneumonia
began
appear
decemb
zhou
et
al
work
remark
speed
identifi
associ
viru
determin
relationship
anim
virus
evalu
factor
confer
infect
suscept
resist
foundat
result
advanc
control
current
worldwid
human
coronaviru
epidem
within
short
time
recogn
novel
infecti
respiratori
syndrom
wuhan
china
dedic
virologist
center
outbreak
complet
groundbreak
work
identifi
agent
diseas
investig
report
zhou
et
al
began
nextgener
sequenc
nucleic
acid
bronchoalveolar
lavag
fluid
diseas
patient
sequenc
data
novel
coronaviru
identifi
provision
name
rna
viru
genom
close
relat
sever
acut
respiratori
syndrom
sar
cov
emerg
human
popul
caus
epidem
diseas
sever
sarsrel
cov
bat
known
potenti
human
infect
thu
renam
alarm
expand
far
beyond
previou
sarscov
spread
countri
infect
individu
februari
infect
associ
sarslik
diseas
case
fatal
rate
diseas
epidem
design
public
health
emerg
intern
concern
world
health
organ
zhou
cowork
set
stage
address
public
health
emerg
develop
quantit
pcrbase
method
detect
infect
use
method
verifi
respiratori
tract
princip
infect
site
establish
preliminari
time
cours
viru
amplif
clearanc
patient
subsequ
detail
clinic
investig
demonstr
detect
within
day
patient
symptom
peak
day
later
clear
within
day
seroconvers
evid
time
abund
virusspecif
igg
measur
approxim
day
diseas
onset
find
help
defin
transmiss
period
inform
public
health
author
appropri
quarantin
measur
addit
shi
group
isol
bronchoalveolar
lavag
fluid
diseas
patient
viru
propag
monkey
human
cell
notabl
parallel
investig
other
demonstr
also
product
infect
primari
human
airway
epitheli
cell
use
vitro
infect
assay
zhou
et
al
discov
convalesc
sera
surviv
patient
convincingli
neutral
infect
moreov
initi
assess
broad
antibodymedi
protect
found
hors
antisarscov
serum
crossneutr
infect
therefor
one
optimist
prospect
broad
antibodymedi
immun
current
futur
zoonot
sarsrel
cov
although
much
work
lie
ahead
identifi
vaccin
elicit
appropri
neutral
antibodi
use
isol
viru
author
subsequ
identifi
critic
host
suscept
factor
cultur
cell
overexpress
transmembran
protein
angiotensin
convert
enzym
protein
human
bat
pig
civet
cat
becam
hypersensit
infect
show
receptor
find
harken
back
earlier
sarscov
also
util
human
anim
protein
receptor
exhibit
zoonot
distribut
match
bind
receptor
ortholog
also
reflect
behavior
middl
east
respiratori
syndrom
mer
cov
subsequ
surfac
proteas
cleav
fusionmedi
subunit
trigger
seri
conform
chang
result
fusion
viral
envelop
target
cell
membran
featur
may
facilit
human
infect
includ
receptorbind
motif
rbm
green
bind
ortholog
receptor
domain
may
confer
addit
host
interact
furin
proteas
cleavag
substrat
may
confer
heighten
sensit
host
proteas
cleavag
antivir
antibodi
lowerleft
inset
prevent
infect
bind
rbm
block
receptor
access
b
bind
distal
rbm
steric
interf
c
bind
possibl
prevent
altern
attach
distinct
receptor
bind
arrest
membran
fusion
attract
antivir
compound
includ
proteas
inhibitor
deactiv
membran
fusion
trigger
suppress
viru
entri
figur
creat
use
biorend
http
biorendercom
although
reli
distinct
dipeptidyl
peptidas
protein
receptor
similarli
dissemin
among
anim
speci
correl
bind
ortholog
find
zhou
colleagu
highlight
interact
enter
viru
host
factor
specif
interact
corona
spike
protein
project
viru
membran
threaten
batderiv
cov
distinct
humantrop
protein
figur
top
insid
human
lung
figur
bottom
protein
interact
host
suscept
factor
includ
receptor
proteas
caus
massiv
protein
conform
chang
trigger
viruscel
membran
fusion
infect
sspecif
neutral
antibodi
antivir
agent
interfer
suscept
factor
protect
infect
report
shi
group
broader
knowledg
cov
entri
frame
import
question
anim
cov
greatest
potenti
human
infect
sarsrel
cov
address
question
amount
identifi
anim
cov
bind
human
receptor
structur
bioinformat
approach
help
even
zhou
et
al
report
insight
made
silico
accur
predict
spike
bind
human
surveil
method
use
cell
cultur
model
address
question
test
human
cell
infect
sarsrel
anim
cov
pay
close
attent
virus
isol
wildlif
close
proxim
human
cov
transmit
human
diseas
recent
structur
biochem
analys
protein
begin
address
question
receptorbind
domain
protein
bind
high
affin
human
may
explain
facil
transmiss
viru
howev
addit
host
interact
may
also
correl
transmiss
diseas
zhou
et
al
note
uniqu
featur
separ
ntermin
domain
protein
may
confer
bind
altern
hostcel
receptor
altern
host
cell
interact
ntermin
domain
warrant
consider
known
analog
domain
sever
human
cov
import
auxiliari
cellbind
function
protein
also
acquir
sever
basic
residu
rrar
form
furin
proteas
cleavag
site
tempor
progress
proteolyt
scission
prime
activ
sarscov
protein
catalyz
viruscel
membran
fusion
thu
furin
substrat
site
like
facilit
prime
cleavag
step
sensit
protein
subsequ
activ
cleavag
occur
suscept
target
cell
facilit
viru
entri
infect
depict
figur
consequ
hypothesi
heighten
proteas
sensit
account
part
transmiss
diseas
certainli
merit
explor
quarantin
measur
place
limit
epidem
risk
global
pandem
real
develop
effect
vaccin
antivir
drug
prioriti
reduc
burden
viru
immedi
challeng
construct
sbase
vaccin
display
conserv
epitop
elicit
broadli
neutral
antibodi
well
virusspecif
cell
respons
similar
daunt
task
lie
ahead
identifi
safe
effect
drug
suppress
entri
replic
make
recommend
clinic
use
given
late
may
modifi
diseas
cours
even
viru
load
diminish
commit
research
commun
build
foundat
knowledg
place
respond
appropri
challeng
